Automedicação com descongestionantes nasais à base de Nafazolina: efeitos adversos e o papel do farmacêutico na orientação ao paciente

Abstract

Self-medication with nasal decongestants containing naphazoline is a common and concerning practice, often associated with prolonged use without medical guidance. This behavior increases the risk of local and systemic adverse effects, such as rhinitis medicamentosa, tachycardia, hypertension, and drug dependence. This study aimed to describe the risks of indiscriminate use of these drugs and highlight the pharmacist's role in prevention and patient guidance. This is an exploratory and descriptive bibliographic research, developed from a literature review in national and international databases (SciELO, PubMed, LILACS, and Google Scholar), prioritizing studies published between 2015 and 2024. Scientific articles, legislation, technical notes, and documents from regulatory bodies such as ANVISA, WHO, and OPAS were consulted. The results showed that sales without a prescription and the mistaken perception of safety contribute to abusive use. In this scenario, the pharmacist plays an essential role in health education, patient monitoring, and promoting the rational use of medications, acting as a crucial link in minimizing risks and preventing complications.